Inhaled and Systemic Steroids for Bronchopulmonary Dysplasia: Targeting Inflammation and Oxidative Stress
Bronchopulmonary dysplasia (BPD) remains a significant complication of preterm birth, characterized by impaired alveolar and vascular development, chronic lung inflammation, and long-term respiratory morbidity. Corticosteroids, both systemic and inhaled, have been widely investigated as potential th...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Antioxidants |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-3921/14/7/869 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849304008443822080 |
|---|---|
| author | Francesca Galletta Alessandra Li Pomi Sara Manti Eloisa Gitto |
| author_facet | Francesca Galletta Alessandra Li Pomi Sara Manti Eloisa Gitto |
| author_sort | Francesca Galletta |
| collection | DOAJ |
| description | Bronchopulmonary dysplasia (BPD) remains a significant complication of preterm birth, characterized by impaired alveolar and vascular development, chronic lung inflammation, and long-term respiratory morbidity. Corticosteroids, both systemic and inhaled, have been widely investigated as potential therapeutic agents due to their anti-inflammatory properties and their emerging role in modulating oxidative stress. This narrative review explores the current evidence regarding the use of inhaled and systemic corticosteroids in the prevention and management of BPD, analyzing their efficacy, safety profiles, and long-term outcomes. While systemic corticosteroids, particularly dexamethasone, have demonstrated benefits in reducing ventilator dependence and lung inflammation, concerns regarding adverse neurodevelopmental effects have limited their routine use. Inhaled steroids have been proposed as a safer alternative, but their role in altering the disease trajectory remains controversial. A better understanding of the optimal timing, dosage, and patient selection is essential to maximize benefits while minimizing risks. Future research should focus on optimizing dosing strategies and identifying subgroups of preterm infants who may derive the greatest benefit from corticosteroid therapy. |
| format | Article |
| id | doaj-art-11a91e8b69754e03b5db687e7ffbbaf6 |
| institution | Kabale University |
| issn | 2076-3921 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Antioxidants |
| spelling | doaj-art-11a91e8b69754e03b5db687e7ffbbaf62025-08-20T03:55:52ZengMDPI AGAntioxidants2076-39212025-07-0114786910.3390/antiox14070869Inhaled and Systemic Steroids for Bronchopulmonary Dysplasia: Targeting Inflammation and Oxidative StressFrancesca Galletta0Alessandra Li Pomi1Sara Manti2Eloisa Gitto3Pediatric Unit, Department of Human Pathology in Adult and Developmental Age ‘Gaetano Barresi’, University of Messina, 98124 Messina, ItalyNeonatal and Pediatric Intensive Care Unit, Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, ItalyPediatric Unit, Department of Human Pathology in Adult and Developmental Age ‘Gaetano Barresi’, University of Messina, 98124 Messina, ItalyNeonatal and Pediatric Intensive Care Unit, Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, ItalyBronchopulmonary dysplasia (BPD) remains a significant complication of preterm birth, characterized by impaired alveolar and vascular development, chronic lung inflammation, and long-term respiratory morbidity. Corticosteroids, both systemic and inhaled, have been widely investigated as potential therapeutic agents due to their anti-inflammatory properties and their emerging role in modulating oxidative stress. This narrative review explores the current evidence regarding the use of inhaled and systemic corticosteroids in the prevention and management of BPD, analyzing their efficacy, safety profiles, and long-term outcomes. While systemic corticosteroids, particularly dexamethasone, have demonstrated benefits in reducing ventilator dependence and lung inflammation, concerns regarding adverse neurodevelopmental effects have limited their routine use. Inhaled steroids have been proposed as a safer alternative, but their role in altering the disease trajectory remains controversial. A better understanding of the optimal timing, dosage, and patient selection is essential to maximize benefits while minimizing risks. Future research should focus on optimizing dosing strategies and identifying subgroups of preterm infants who may derive the greatest benefit from corticosteroid therapy.https://www.mdpi.com/2076-3921/14/7/869bronchopulmonary dysplasiasystemic steroidsinhaled steroidslung injuryinflammationoxidative stress |
| spellingShingle | Francesca Galletta Alessandra Li Pomi Sara Manti Eloisa Gitto Inhaled and Systemic Steroids for Bronchopulmonary Dysplasia: Targeting Inflammation and Oxidative Stress Antioxidants bronchopulmonary dysplasia systemic steroids inhaled steroids lung injury inflammation oxidative stress |
| title | Inhaled and Systemic Steroids for Bronchopulmonary Dysplasia: Targeting Inflammation and Oxidative Stress |
| title_full | Inhaled and Systemic Steroids for Bronchopulmonary Dysplasia: Targeting Inflammation and Oxidative Stress |
| title_fullStr | Inhaled and Systemic Steroids for Bronchopulmonary Dysplasia: Targeting Inflammation and Oxidative Stress |
| title_full_unstemmed | Inhaled and Systemic Steroids for Bronchopulmonary Dysplasia: Targeting Inflammation and Oxidative Stress |
| title_short | Inhaled and Systemic Steroids for Bronchopulmonary Dysplasia: Targeting Inflammation and Oxidative Stress |
| title_sort | inhaled and systemic steroids for bronchopulmonary dysplasia targeting inflammation and oxidative stress |
| topic | bronchopulmonary dysplasia systemic steroids inhaled steroids lung injury inflammation oxidative stress |
| url | https://www.mdpi.com/2076-3921/14/7/869 |
| work_keys_str_mv | AT francescagalletta inhaledandsystemicsteroidsforbronchopulmonarydysplasiatargetinginflammationandoxidativestress AT alessandralipomi inhaledandsystemicsteroidsforbronchopulmonarydysplasiatargetinginflammationandoxidativestress AT saramanti inhaledandsystemicsteroidsforbronchopulmonarydysplasiatargetinginflammationandoxidativestress AT eloisagitto inhaledandsystemicsteroidsforbronchopulmonarydysplasiatargetinginflammationandoxidativestress |